On the Record · Hologic
Hologic competitors, on the record
The companies Hologic names as competitors in its annual reports, 2023 to 2025, and the companies that name Hologic, each with the sentence and the filing.
Who Hologic names
| Company | Named in |
|---|---|
| Abbott Laboratories | 2025 |
| Becton Dickinson | 2025 |
| Cepheid | 2025 |
| F. Hoffmann-LaRoche Ltd | 2025 |
| GE Healthcare | 2025 |
| Johnson & Johnson | 2025 |
| Medtronic | 2025 |
| Roche Diagnostics | 2025 |
| Siemens Healthineers | 2025 |
In its own words
Abbott Laboratories, Becton Dickinson, Cepheid, Roche Diagnostics
Word for word“In our Diagnostics business, our primary competitors include Roche Diagnostics, Abbott Laboratories and Cepheid in the molecular diagnostics field, and Becton Dickinson in the cytology field, as well as a wide range of diagnostics companies that sell a single or limited number of assays or products in only a specific market segment (i.e., Cytology, Acute Care, or Oncology Services).” 10-K for 2025
F. Hoffmann-LaRoche Ltd
Word for word“For example, F. Hoffmann-LaRoche Ltd, a direct competitor of our Diagnostics business, is the parent company of Roche, our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays.” 10-K for 2025
GE Healthcare, Siemens Healthineers
Word for word“In our Breast & Skeletal Health business, our primary competitors are large imaging companies such as Siemens Healthineers and GE Healthcare, as well as a wide range of medical technology companies that sell a subset of technology solutions into a specific market segment (i.e., Breast Biopsy, Breast Surgery).” 10-K for 2025
Johnson & Johnson, Medtronic
Word for word“In our GYN Surgical business, our primary competitors are large, full suite surgical solutions companies such as Johnson & Johnson and Medtronic, as well as a wide range of single technology or solutions companies that sell into a specific market segment or procedure.” 10-K for 2025
Who names Hologic
Companies whose own annual reports name Hologic as a competitor.
Word for word“Our Alere i and Alere q point-of-care analyzers compete with larger, laboratory-based analyzers from companies including Abbott, Becton Dickinson, Cepheid (which was acquired by Danaher in November 2016), Hologic and Roche, which also offer molecular technologies for amplifying DNA and RNA.” 10-K for 2016
Word for word“Larger companies such as Johnson & Johnson, Baxter International, Medtronic and Hologic have offerings that compete with our medical device products.” 10-K for 2025
Word for word“These companies include Agendia Inc., Veracyte, Inc., Myriad Genetics, Inc., and Hologic, Inc.” 10-K for 2025
Word for word“Our primary competitors in our oncology market are BD, Hologic, Inc., Argon Medical Devices, Inc. and Cook Medical.” 10-K for 2025
Word for word“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and Wermerson Immuncor.” 10-K for 2025
Read from Hologic’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2025-11-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.